Principal Financial Group’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $31.5K | Buy |
|
|||||
|
2023
Q4 | $16.3K | Sell |
|
|||||
|
2023
Q3 | $22.1K | Hold |
|
|||||
|
2023
Q2 | $53.4K | Buy |
|
|||||
|
2023
Q1 | $73.2K | Sell |
|
|||||
|
2022
Q4 | $93.9K | Buy |
|
|||||
|
2022
Q3 | $184K | Buy |
|
|||||
|
2022
Q2 | $169K | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $307K | Sell |
|
|||||
|
2021
Q2 | $335K | Buy |
|
|||||
|
2021
Q1 | $445K | Buy |
|
|||||
|
2020
Q4 | $431K | Sell |
|
|||||
|
2020
Q3 | $781K | Buy |
|
|||||
|
2020
Q2 | $650K | Buy |
|